StockMacro
Menu

Healthcare Realty Trust

$19.36 -5.8% in 6 monthsMarket cap $6.6B

HR on XNYS, Real Estate, Healthcare Realty Trust Incorporated, job postings

Measures activity, not value. Not investment advice.

Revenue fell 5.8% to $1.1B in 12 months and posted a $44.9M loss while shares rose 11% in a year.

  • BadLatest quarter revenue down 3.7% to $286.6M from $297.8M
  • WatchDebt of $4.2B against $17.5M of cash on the balance sheet

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.

Industry
Real estate investment trusts (Real Estate)
Employees
539
Website
healthcarerealty.com
Listed
NYSE, US
Last results
29 Oct 2026
Next results
expected around 11 Feb 2027 (an estimate: a year ago it reported on 12 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $286.6M, net loss $15.8M.
Quarter to 31 Dec 2021: revenue $195.7M, net income $16.3MQuarter to 31 Dec 2021: revenue $195.7M, net income $16.3MQuarter to 31 Mar 2022: revenue $202.0M, net income $18.3MQuarter to 31 Mar 2022: revenue $202.0M, net income $18.3MQuarter to 30 Jun 2022: revenue $145.3M, net income $6.1MQuarter to 30 Jun 2022: revenue $145.3M, net income $6.1MQuarter to 30 Sep 2022: revenue $306.4M, net income $28.3MQuarter to 30 Sep 2022: revenue $306.4M, net income $28.3MQuarter to 31 Mar 2023: revenue $332.9M, net income -$87.1MQuarter to 31 Mar 2023: revenue $332.9M, net income -$87.1MQuarter to 30 Jun 2023: revenue $338.1M, net income -$82.8MQuarter to 30 Jun 2023: revenue $338.1M, net income -$82.8MQuarter to 30 Sep 2023: revenue $342.3M, net income -$67.8MQuarter to 30 Sep 2023: revenue $342.3M, net income -$67.8MQuarter to 31 Mar 2024: revenue $326.8M, net income -$310.8MQuarter to 31 Mar 2024: revenue $326.8M, net income -$310.8MQuarter to 30 Jun 2024: revenue $316.3M, net income -$143.8MQuarter to 30 Jun 2024: revenue $316.3M, net income -$143.8MQuarter to 30 Sep 2024: revenue $315.4M, net income -$93.0MQuarter to 30 Sep 2024: revenue $315.4M, net income -$93.0MQuarter to 31 Dec 2024: revenue $309.8M, net income -$106.8MQuarter to 31 Dec 2024: revenue $309.8M, net income -$106.8MQuarter to 31 Mar 2025: revenue $299.0M, net income -$44.9MQuarter to 31 Mar 2025: revenue $299.0M, net income -$44.9MQuarter to 30 Jun 2025: revenue $297.5M, net income -$157.9MQuarter to 30 Jun 2025: revenue $297.5M, net income -$157.9MQuarter to 30 Sep 2025: revenue $297.8M, net income -$57.7MQuarter to 30 Sep 2025: revenue $297.8M, net income -$57.7MQuarter to 31 Dec 2025: revenue $286.3M, net income $14.4MQuarter to 31 Dec 2025: revenue $286.3M, net income $14.4MQuarter to 31 Mar 2026: revenue $279.0M, net income -$56KQuarter to 31 Mar 2026: revenue $279.0M, net income -$56KQuarter to 30 Jun 2026: revenue $281.8M, net income -$43.5MQuarter to 30 Jun 2026: revenue $281.8M, net income -$43.5MQuarter to 30 Sep 2026: revenue $286.6M, net income -$15.8MQuarter to 30 Sep 2026: revenue $286.6M, net income -$15.8M
31 Dec 2021RevenueNet incomeNet losstallest bar $342.3M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$286.6M-$15.8M
30 Jun 2026$281.8M-$43.5M
31 Mar 2026$279.0M-$56K
31 Dec 2025$286.3M$14.4M
30 Sep 2025$297.8M-$57.7M
30 Jun 2025$297.5M-$157.9M
31 Mar 2025$299.0M-$44.9M
31 Dec 2024$309.8M-$106.8M
30 Sep 2024$315.4M-$93.0M
30 Jun 2024$316.3M-$143.8M
31 Mar 2024$326.8M-$310.8M
30 Sep 2023$342.3M-$67.8M
30 Jun 2023$338.1M-$82.8M
31 Mar 2023$332.9M-$87.1M
30 Sep 2022$306.4M$28.3M
30 Jun 2022$145.3M$6.1M
31 Mar 2022$202.0M$18.3M
31 Dec 2021$195.7M$16.3M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $1.1B $1.2B
Revenue growthRevenue of the last 12 months compared with the 12 months before. -5.8% +5.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$44.9M -$367.3M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.14 -$1.07
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 68.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – 37.9%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -4.0% -30.5% 14.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -1.0% 4.4%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $17.5M $43.3M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $4.2B $4.5B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $4.2B $4.4B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 1.0 1.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $12.05
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 24.5
P/SPrice to sales: market cap divided by revenue of the last 12 months. 5.8 4.5
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 9.5 9.8
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.6 1.1
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 5.7% 5.1%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Healthcare Realty TrustHR (this company) $6.6Bloss5.8-5.8%-4.0%
MacerichMAC $6.6Bloss6.5-1.3%-9.8%
Stag IndustrialSTAG $6.9B25.87.7+9.3%29.9%
Essential Properties Realty TrustEPRT $6.2B23.59.6+20%41.0%
Alexandria Real Estate EquitiesARE $7.0Bloss–––
First Industrial Realty TrustFR $7.0B19.39.3+8.4%48.0%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$401K

bought $0, sold $401K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+3.1%

461 13F filers vs 447

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

363.2M shares held by 13F filers (30 Sep 2026) of 338.5M outstanding (26 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

5.0%

17.0M shares sold short (30 Oct 2026) of 338.5M outstanding (26 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

2.6

17.0M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-3.0%

17.5M shares sold short in the report before, 17.0M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

41%

41% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 54%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-3.7%

$286.6M vs $297.8M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

14

14 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

14×

14 articles in the last 7 days; its usual week has 1.

Price $19.36 on 20 Nov 2026, +11% over 12 months (12-month range $16.34 to $21.87)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $745K in the last 12 months (the 12 months before: $45K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 2 published in the last 12 months, -33% on the 12 months before.
Revenue per quarter. Revenue $286.6M in the latest quarter, -3.7% on a year earlier.
Capital spending per quarter. Capital spending $600K in the latest quarter.
Institutional holders (13F filers). 461 13F filers reported holding it in the latest 13F quarter, +19% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
23 Feb 20268-K and other filingsChanged its auditor
7 Jan 20268-K and other filingsDirector or officer change
7 Jan 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Sep 2025Sharp changeShort interest spike: short interest spike, 20.0M vs usual 13.0M (2025-09-15); 1.4x the same period a year earlier
16 Sep 2025Sharp changeShort interest spike: short interest spike, 19.5M vs usual 13.0M (2025-08-29); 1.3x the same period a year earlier
23 Jun 20258-K and other filingsDirector or officer change
22 May 20258-K and other filingsDirector or officer change
7 Apr 20258-K and other filingsDirector or officer change
7 Apr 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Dec 2024Sharp changeClustered insider buying: clustered insider buying (4 independent filers, 5 filing(s) in 30 days, value_usd total 492K)
9 Dec 20248-K and other filingsDirector or officer change
9 Dec 20248-K and other filingsDirector or officer change
12 Nov 20248-K and other filingsDirector or officer change
16 Sep 20248-K and other filingsDirector or officer change
7 Sep 2024Sharp changeClustered insider buying: clustered insider buying (4 independent filers, 6 filing(s) in 30 days, value_usd total 892K)
13 Aug 2024Sharp changeShort interest spike: short interest spike, 20.2M vs usual 11.5M (2024-07-31); 1.6x the same period a year earlier
25 Jun 20248-K and other filingsDirector or officer change
25 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
4 Mar 20248-K and other filingsDirector or officer change
4 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Mar 2023Sharp changeQuarterly revenue change: quarterly revenue change, 4.4M vs usual 188.0M (2022-12-31); 0.0x the same period a year earlier
15 Nov 2022Sharp changeMany funds opening a new position: many funds opening a new position, 148 vs usual 32.50 (2022-09-30); 6.2x the same period a year earlier
15 Nov 2022Sharp changeQuarterly revenue change: quarterly revenue change, 4.1M vs usual 188.0M (2022-09-30); 0.0x the same period a year earlier
16 Aug 2022Sharp changeShort interest spike: short interest spike, 18.7M vs usual 5.5M (2022-07-29); 3.6x the same period a year earlier
16 Aug 2022Sharp changeQuarterly revenue change: quarterly revenue change, 2.7M vs usual 188.0M (2022-06-30); 0.0x the same period a year earlier
5 Aug 20228-K and other filingsDirector or officer change
5 Aug 20228-K and other filingsChanged its auditor
2 Aug 2022Sharp changeShort interest spike: short interest spike, 25.0M vs usual 5.5M (2022-07-15); 4.5x the same period a year earlier
26 Jul 20228-K and other filingsDirector or officer change
26 Jul 20228-K and other filingsChanged its auditor
26 Jul 20228-K and other filingsDelisting notice or listing transfer
26 Jul 20228-K and other filingsCompleted an acquisition or asset sale
26 Jul 20228-K and other filingsA major agreement ended
26 Jul 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Jul 2022Sharp changeShort interest spike: short interest spike, 21.0M vs usual 5.4M (2022-06-30); 3.8x the same period a year earlier
28 Jun 2022Sharp changeShort interest spike: short interest spike, 24.0M vs usual 5.3M (2022-06-15); 6.1x the same period a year earlier
14 Jun 2022Sharp changeShort interest spike: short interest spike, 19.6M vs usual 5.2M (2022-05-31); 7.4x the same period a year earlier
31 May 2022Sharp changeShort interest spike: short interest spike, 18.9M vs usual 5.2M (2022-05-13); 6.4x the same period a year earlier
17 May 2022Sharp changeShort interest spike: short interest spike, 25.2M vs usual 5.1M (2022-04-29); 4.6x the same period a year earlier
3 May 2022Sharp changeShort interest spike: short interest spike, 22.0M vs usual 5.1M (2022-04-14); 4.3x the same period a year earlier
12 Apr 2022Sharp changeShort interest spike: short interest spike, 22.0M vs usual 4.9M (2022-03-31); 5.6x the same period a year earlier
29 Mar 2022Sharp changeShort interest spike: short interest spike, 18.7M vs usual 4.4M (2022-03-15); 6.0x the same period a year earlier
15 Mar 20228-K and other filingsDirector or officer change
14 Mar 20228-K and other filingsDirector or officer change
14 Mar 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2022: -$285K published
Month from 1 Mar 2023: $238K published
Month from 1 Aug 2023: $539K published
Month from 1 Dec 2023: -$503K published
Month from 1 Aug 2024: $261K published
Month from 1 Sep 2024: $631K published
Month from 1 Nov 2024: $204K published
Month from 1 Dec 2024: $114K published
Month from 1 May 2025: $37K published
Month from 1 Aug 2025: $165K published
Month from 1 Sep 2025: -$270K published
Month from 1 Mar 2026: $181K published
Month from 1 Jun 2026: -$525K published
Month from 1 Sep 2026: -$401K published
H-1B/E-3 applications certified
Quarter from 1 Jul 2023: 1 published
Quarter from 1 Jan 2024: 1 published
Quarter from 1 Jul 2025: 1 published
Quarter from 1 Oct 2025: 2 published
Quarter from 1 Jul 2026: 2 published
Revenue per quarter
Quarter ended 31 Dec 2021: $195.7M, +4.6% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $202.0M, +5.5% on a year earlier; public on 10 May 2022
Quarter ended 30 Jun 2022: $145.3M, -23% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $306.4M, +60% on a year earlier; public on 10 Nov 2022
Quarter ended 31 Mar 2023: $332.9M, +65% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $338.1M, +133% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $342.3M, +12% on a year earlier; public on 4 Nov 2023
Quarter ended 31 Mar 2024: $326.8M, -1.8% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $316.3M, -6.5% on a year earlier; public on 3 Aug 2024
Quarter ended 30 Sep 2024: $315.4M, -7.8% on a year earlier; public on 31 Oct 2024
Quarter ended 31 Dec 2024: $309.8M; public on 20 Feb 2025
Quarter ended 31 Mar 2025: $299.0M, -8.5% on a year earlier; public on 2 May 2025
Quarter ended 30 Jun 2025: $297.5M, -5.9% on a year earlier; public on 2 Aug 2025
Quarter ended 30 Sep 2025: $297.8M, -5.6% on a year earlier; public on 1 Nov 2025
Quarter ended 31 Dec 2025: $286.3M, -7.6% on a year earlier; public on 14 Feb 2026
Quarter ended 31 Mar 2026: $279.0M, -6.7% on a year earlier; public on 2 May 2026
Quarter ended 30 Jun 2026: $281.8M, -5.3% on a year earlier; public on 31 Jul 2026
Quarter ended 30 Sep 2026: $286.6M, -3.7% on a year earlier; public on 30 Oct 2026
Capital spending per quarter
Quarter ended 30 Sep 2023: $600K; public on 4 Nov 2023
Institutional holders (13F filers)
31 Dec 2021 report: 273; public on 14 Feb 2022
31 Mar 2022 report: 290; public on 16 May 2022
30 Jun 2022 report: 271; public on 15 Aug 2022
30 Sep 2022 report: 358; public on 14 Nov 2022
31 Dec 2022 report: 375; public on 14 Feb 2023
31 Mar 2023 report: 388; public on 15 May 2023
30 Jun 2023 report: 363; public on 14 Aug 2023
30 Sep 2023 report: 362; public on 14 Nov 2023
31 Dec 2023 report: 381; public on 14 Feb 2024
31 Mar 2024 report: 372; public on 15 May 2024
30 Jun 2024 report: 366; public on 14 Aug 2024
30 Sep 2024 report: 379; public on 14 Nov 2024
31 Dec 2024 report: 400; public on 14 Feb 2025
31 Mar 2025 report: 402; public on 15 May 2025
30 Jun 2025 report: 389; public on 14 Aug 2025
30 Sep 2025 report: 388; public on 14 Nov 2025
31 Dec 2025 report: 404; public on 17 Feb 2026
31 Mar 2026 report: 433; public on 15 May 2026
30 Jun 2026 report: 447; public on 14 Aug 2026
30 Sep 2026 report: 461; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $401K (9 Sep 2026), higher than 74% of its own history.
  • Insider net buying (open market): Insiders sold a net $745K in the last 12 months (the 12 months before: $45K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 2 published in the last 12 months, -33% on the 12 months before.
  • Revenue per quarter: Revenue $286.6M in the latest quarter, -3.7% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 50 insider trades

Last 90 days: 1 sale, $401K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
9 Sep 2026Robert E HullEVP and COOSell21,000$19.11$401KForm 4
23 Jun 2026Amanda L CallawaySVP & Chief Accounting OfficerSell25,767$20.37$525KForm 4
6 Mar 2026Thomas N BohjalianDirectorBuy10,000$18.09$181KForm 4
5 Mar 2026Daniel GabbayEVP, Chief Financial OfficerBuy10$18.74$187Form 4
5 Sep 2025Julie F. WilsonEVP, Chief Admin. OfficerSell15,000$18.00$270KForm 4
13 Aug 2025Thomas N BohjalianDirectorBuy10,000$16.46$165KForm 4
14 May 2025Thomas N BohjalianDirectorBuy2,500$14.71$37KForm 4
20 Dec 2024Jay P LeuppDirectorBuy1,000$16.85$17KForm 4

461 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 51 opened a position, 40 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.57.7M17.0%$1.0B+658K+1.2%
Cohen & Steers, Inc.48.9M14.4%-4.4M-8.3%
Vanguard Portfolio Management LLC28.9M8.53%$512.2M-177K-0.6%
State Street Corp16.9M4.98%$299.3M+125K+0.7%
Vanguard Capital Management LLC15.2M4.50%$270.4M-335K-2.2%
T. Rowe Price Associates Inc13.9M4.11%-2.2M-14%
Resolution Capital Ltd11.9M3.52%$211.4M-219K-1.8%
APG Asset Management US Inc.10.2M3.02%$178.2MNo change
Geode Capital Management, LLC8.2M2.42%$145.4M+887K+12%
Charles Schwab Investment Management Inc7.8M2.32%$139.1M+402K+5.4%

Company events

All 57 company events

In 12 months: 3 major agreements, 1 director or officer change, 1 auditor change. Results releases and routine reports are left out.

FiledWhat happenedSource
19 May 2026Signed a major agreementSame filing: took on new debt8-K
7 May 2026Signed a major agreementSame filing: took on new debt, sold shares privately8-K
23 Feb 2026Changed its auditor8-K
7 Jan 2026Director or officer change8-K
17 Dec 2025Signed a major agreement8-K
31 Jul 2025Signed a major agreementSame filing: took on new debt8-K
23 Jun 2025Director or officer change8-K
22 May 2025Director or officer changeSame filing: shareholder vote results8-K

The 5 newest of 129 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

7 Sep 2024confirmed

Confirmed across sources Insiders and Short interest and volume

Healthcare Realty Trust (HR): had 20.2M shares sold short in the 31 Jul 2024 report, 1.6× the same report last year, while it had 4 insiders buy $892K of its shares on the open market within 30 days (6 filings). Two unrelated kinds of activity within 24 days.

  • Short interest and volume: Short interest spike, became public on 10 Aug 2024
  • Insiders: Clustered insider buying, became public on 7 Sep 2024
2023-07-31: 12.3M2023-08-15: 12.2M2023-08-31: 11.9M2023-09-15: 11.5M2023-09-29: 11.5M2023-10-13: 13.6M2023-10-31: 12.4M2023-11-15: 12.4M2023-11-30: 12.4M2023-12-15: 10.7M2023-12-29: 10.0M2024-01-12: 9.4M2024-01-31: 8.8M2024-02-15: 9.6M2024-02-29: 10.1M2024-03-15: 7.5M2024-03-28: 9.1M2024-04-15: 7.3M2024-04-30: 10.1M2024-05-15: 11.0M2024-05-31: 14.5M2024-06-14: 15.6M2024-06-28: 15.0M2024-07-15: 15.3M2024-07-31: 20.2M
The 31 Jul 2024 report against the 24 reports before it. this reportearliernormal: 11.5M
See the evidence (2 changes)

Short interest and volume: Short interest spike became public on 10 Aug 2024

Healthcare Realty Trust had 20.2M shares sold short in the 31 Jul 2024 report, 1.6× the same report last year.

This period
20.2M (the 31 Jul 2024 report)
Normal report (median of 24 earlier)
11.5M
Typical spread (median absolute deviation)
1.4M
How far from its usual level
+4.1
Same report last year
12.3M
History used
2,406 days
2023-07-31: 12.3M2023-08-15: 12.2M2023-08-31: 11.9M2023-09-15: 11.5M2023-09-29: 11.5M2023-10-13: 13.6M2023-10-31: 12.4M2023-11-15: 12.4M2023-11-30: 12.4M2023-12-15: 10.7M2023-12-29: 10.0M2024-01-12: 9.4M2024-01-31: 8.8M2024-02-15: 9.6M2024-02-29: 10.1M2024-03-15: 7.5M2024-03-28: 9.1M2024-04-15: 7.3M2024-04-30: 10.1M2024-05-15: 11.0M2024-05-31: 14.5M2024-06-14: 15.6M2024-06-28: 15.0M2024-07-15: 15.3M2024-07-31: 20.2M
the 31 Jul 2024 report24 earlier reportsnormal: 11.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Insiders: Clustered insider buying became public on 7 Sep 2024

Healthcare Realty Trust had 4 insiders buy $892K of its shares on the open market within 30 days (6 filings).

Independent buyers
4
Purchase filings (Form 4, code P)
6
Total bought
$892K
Window
8 Aug 2024 to 7 Sep 2024

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

15 Nov 2022confirmed

Confirmed across sources Institutional holdings and Filings + Financials

Healthcare Realty Trust (HR): saw 148 13F filers open a new position in the quarter ended 30 Sep 2022, 6.2× the same quarter last year, while it reported revenue of $4.1M for the quarter ended 30 Sep 2022, 98% below the same quarter last year. Two unrelated kinds of activity on the same day.

  • Institutional holdings: Many funds opening a new position, became public on 14 Nov 2022
  • Financials: Quarterly revenue change, became public on 15 Nov 2022
2020-09-30: 362020-12-31: 432021-03-31: 172021-06-30: 172021-09-30: 242021-12-31: 322022-03-31: 492022-06-30: 332022-09-30: 148
The quarter ended 30 Sep 2022 against the 8 quarters before it. this quarterearliernormal: 32.5
See the evidence (2 changes)

Institutional holdings: Many funds opening a new position became public on 14 Nov 2022

Healthcare Realty Trust saw 148 13F filers open a new position in the quarter ended 30 Sep 2022, 6.2× the same quarter last year.

This period
148 (the quarter ended 30 Sep 2022)
Normal quarter (median of 8 earlier)
32.5
Typical spread (median absolute deviation)
9.5
How far from its usual level
+8.2
Same quarter last year
24
History used
3,287 days
2020-09-30: 362020-12-31: 432021-03-31: 172021-06-30: 172021-09-30: 242021-12-31: 322022-03-31: 492022-06-30: 332022-09-30: 148
the quarter ended 30 Sep 20228 earlier quartersnormal: 32.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Financials: Quarterly revenue change became public on 15 Nov 2022

Healthcare Realty Trust reported revenue of $4.1M for the quarter ended 30 Sep 2022, 98% below the same quarter last year.

This period
$4.1M (the quarter ended 30 Sep 2022)
Normal quarter (median of 8 earlier)
$188.0M
Typical spread (median absolute deviation)
$3.4M
How far from its usual level
-9.8
Same quarter last year
$191.3M
History used
4,475 days
2020-06-30: $178.8M2020-09-30: $187.3M2020-12-31: $187.0M2021-03-31: $191.5M2021-06-30: $188.6M2021-09-30: $191.3M2021-12-31: $195.7M2022-06-30: $2.7M2022-09-30: $4.1M
the quarter ended 30 Sep 20228 earlier quartersnormal: $188.0M

Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

16 Aug 2022confirmed

Confirmed across sources Filings + Financials and Short interest and volume

Healthcare Realty Trust (HR): had 25.0M shares sold short in the 15 Jul 2022 report, 4.5× the same report last year, while it reported revenue of $2.7M for the quarter ended 30 Jun 2022, 99% below the same quarter last year. Two unrelated kinds of activity within 28 days.

  • Short interest and volume: Short interest spike, became public on 13 Jul 2022
  • Short interest and volume: Short interest spike, became public on 27 Jul 2022
  • Financials: Quarterly revenue change, became public on 16 Aug 2022
  • Short interest and volume: Short interest spike, became public on 10 Aug 2022
2021-06-30: 5.6M2021-07-15: 5.5M2021-07-30: 5.2M2021-08-13: 5.5M2021-08-31: 6.8M2021-09-15: 5.2M2021-09-30: 5.4M2021-10-15: 4.1M2021-10-29: 3.4M2021-11-15: 3.0M2021-11-30: 3.0M2021-12-15: 3.4M2022-01-14: 4.0M2022-01-31: 4.8M2022-02-15: 5.1M2022-02-28: 5.5M2022-03-15: 18.7M2022-03-31: 22.0M2022-04-14: 22.0M2022-04-29: 25.2M2022-05-13: 18.9M2022-05-31: 19.6M2022-06-15: 24.0M2022-06-30: 21.0M2022-07-15: 25.0M
The 15 Jul 2022 report against the 24 reports before it. this reportearliernormal: 5.5M
See the evidence (4 changes)

Short interest and volume: Short interest spike became public on 13 Jul 2022

Healthcare Realty Trust had 21.0M shares sold short in the 30 Jun 2022 report, 3.8× the same report last year.

This period
21.0M (the 30 Jun 2022 report)
Normal report (median of 24 earlier)
5.4M
Typical spread (median absolute deviation)
1.5M
How far from its usual level
+7.1
Same report last year
5.6M
History used
1,644 days
2021-06-15: 3.9M2021-06-30: 5.6M2021-07-15: 5.5M2021-07-30: 5.2M2021-08-13: 5.5M2021-08-31: 6.8M2021-09-15: 5.2M2021-09-30: 5.4M2021-10-15: 4.1M2021-10-29: 3.4M2021-11-15: 3.0M2021-11-30: 3.0M2021-12-15: 3.4M2022-01-14: 4.0M2022-01-31: 4.8M2022-02-15: 5.1M2022-02-28: 5.5M2022-03-15: 18.7M2022-03-31: 22.0M2022-04-14: 22.0M2022-04-29: 25.2M2022-05-13: 18.9M2022-05-31: 19.6M2022-06-15: 24.0M2022-06-30: 21.0M
the 30 Jun 2022 report24 earlier reportsnormal: 5.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Jul 2022

Healthcare Realty Trust had 25.0M shares sold short in the 15 Jul 2022 report, 4.5× the same report last year.

This period
25.0M (the 15 Jul 2022 report)
Normal report (median of 24 earlier)
5.5M
Typical spread (median absolute deviation)
1.8M
How far from its usual level
+7.4
Same report last year
5.5M
History used
1,659 days
2021-06-30: 5.6M2021-07-15: 5.5M2021-07-30: 5.2M2021-08-13: 5.5M2021-08-31: 6.8M2021-09-15: 5.2M2021-09-30: 5.4M2021-10-15: 4.1M2021-10-29: 3.4M2021-11-15: 3.0M2021-11-30: 3.0M2021-12-15: 3.4M2022-01-14: 4.0M2022-01-31: 4.8M2022-02-15: 5.1M2022-02-28: 5.5M2022-03-15: 18.7M2022-03-31: 22.0M2022-04-14: 22.0M2022-04-29: 25.2M2022-05-13: 18.9M2022-05-31: 19.6M2022-06-15: 24.0M2022-06-30: 21.0M2022-07-15: 25.0M
the 15 Jul 2022 report24 earlier reportsnormal: 5.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Financials: Quarterly revenue change became public on 16 Aug 2022

Healthcare Realty Trust reported revenue of $2.7M for the quarter ended 30 Jun 2022, 99% below the same quarter last year.

This period
$2.7M (the quarter ended 30 Jun 2022)
Normal quarter (median of 8 earlier)
$188.0M
Typical spread (median absolute deviation)
$2.7M
How far from its usual level
-9.9
Same quarter last year
$188.6M
History used
4,383 days
2020-03-31: $185.8M2020-06-30: $178.8M2020-09-30: $187.3M2020-12-31: $187.0M2021-03-31: $191.5M2021-06-30: $188.6M2021-09-30: $191.3M2021-12-31: $195.7M2022-06-30: $2.7M
the quarter ended 30 Jun 20228 earlier quartersnormal: $188.0M

Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 10 Aug 2022

Healthcare Realty Trust had 18.7M shares sold short in the 29 Jul 2022 report, 3.6× the same report last year.

This period
18.7M (the 29 Jul 2022 report)
Normal report (median of 24 earlier)
5.5M
Typical spread (median absolute deviation)
2.1M
How far from its usual level
+4.3
Same report last year
5.2M
History used
1,673 days
2021-07-15: 5.5M2021-07-30: 5.2M2021-08-13: 5.5M2021-08-31: 6.8M2021-09-15: 5.2M2021-09-30: 5.4M2021-10-15: 4.1M2021-10-29: 3.4M2021-11-15: 3.0M2021-11-30: 3.0M2021-12-15: 3.4M2022-01-14: 4.0M2022-01-31: 4.8M2022-02-15: 5.1M2022-02-28: 5.5M2022-03-15: 18.7M2022-03-31: 22.0M2022-04-14: 22.0M2022-04-29: 25.2M2022-05-13: 18.9M2022-05-31: 19.6M2022-06-15: 24.0M2022-06-30: 21.0M2022-07-15: 25.0M2022-07-29: 18.7M
the 29 Jul 2022 report24 earlier reportsnormal: 5.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 7 Mar 2026Insiders record

    Bohjalian Thomas N (director) bought 10,000 shares of HR ($180,900) (dated 6 Mar 2026)

  2. 6 Mar 2026Insiders record

    Gabbay Daniel (EVP, Chief Financial Officer) bought 10 shares of HR ($187) (dated 5 Mar 2026)

  3. 23 Feb 2026Filings record

    Changed its auditor

  4. 7 Jan 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  5. 7 Jan 2026Filings record

    Director or officer change

  6. 25 Sep 2025Short interest and volume change

    had 20.0M shares sold short in the 15 Sep 2025 report, 1.4× the same report last year.

    Same report last year: 13.9M; its normal report is 13.0M.

    See the evidence
    This period
    20.0M (the 15 Sep 2025 report)
    Normal report (median of 24 earlier)
    13.0M
    Typical spread (median absolute deviation)
    1.1M
    How far from its usual level
    +4.3
    Same report last year
    13.9M
    History used
    2,817 days
    2024-09-13: 13.9M2024-09-30: 13.0M2024-10-15: 13.8M2024-10-31: 11.3M2024-11-15: 14.7M2024-11-29: 15.1M2024-12-13: 14.3M2024-12-31: 12.9M2025-01-15: 14.0M2025-01-31: 13.1M2025-02-14: 10.6M2025-02-28: 11.2M2025-03-14: 9.8M2025-03-31: 9.4M2025-04-15: 12.6M2025-04-30: 11.9M2025-05-15: 14.2M2025-05-30: 12.4M2025-06-13: 12.5M2025-06-30: 11.1M2025-07-15: 12.1M2025-07-31: 13.5M2025-08-15: 17.4M2025-08-29: 19.5M2025-09-15: 20.0M
    the 15 Sep 2025 report24 earlier reportsnormal: 13.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 11 Sep 2025Short interest and volume change

    had 19.5M shares sold short in the 29 Aug 2025 report, 1.3× the same report last year.

    Same report last year: 15.3M; its normal report is 13.0M.

    See the evidence
    This period
    19.5M (the 29 Aug 2025 report)
    Normal report (median of 24 earlier)
    13.0M
    Typical spread (median absolute deviation)
    1.1M
    How far from its usual level
    +3.9
    Same report last year
    15.3M
    History used
    2,800 days
    2024-08-30: 15.3M2024-09-13: 13.9M2024-09-30: 13.0M2024-10-15: 13.8M2024-10-31: 11.3M2024-11-15: 14.7M2024-11-29: 15.1M2024-12-13: 14.3M2024-12-31: 12.9M2025-01-15: 14.0M2025-01-31: 13.1M2025-02-14: 10.6M2025-02-28: 11.2M2025-03-14: 9.8M2025-03-31: 9.4M2025-04-15: 12.6M2025-04-30: 11.9M2025-05-15: 14.2M2025-05-30: 12.4M2025-06-13: 12.5M2025-06-30: 11.1M2025-07-15: 12.1M2025-07-31: 13.5M2025-08-15: 17.4M2025-08-29: 19.5M
    the 29 Aug 2025 report24 earlier reportsnormal: 13.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 14 Aug 2025Insiders record

    Bohjalian Thomas N (director) bought 10,000 shares of HR ($164,600) (dated 13 Aug 2025)

  9. 23 Jun 2025Filings record

    Director or officer change

  10. 22 May 2025Filings record

    Director or officer change

  11. 15 May 2025Insiders record

    Bohjalian Thomas N (director) bought 2,500 shares of HR ($36,775) (dated 14 May 2025)

  12. 7 Apr 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  13. 7 Apr 2025Filings record

    Director or officer change

  14. 21 Dec 2024Insiders change

    had 4 insiders buy $492K of its shares on the open market within 30 days (5 filings).

    Who bought: Bohjalian Thomas N, Lyle Peter F SR, Wood Donald C, Leupp Jay P.

    See the evidence (5 source records)
    Independent buyers
    4
    Purchase filings (Form 4, code P)
    5
    Total bought
    $492K
    Window
    21 Nov 2024 to 21 Dec 2024

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  15. 21 Dec 2024Insiders record

    Leupp Jay P (director) bought 1,000 shares of HR ($16,850) (dated 20 Dec 2024)

  16. 21 Dec 2024Insiders record

    WOOD DONALD C (director) bought 5,900 shares of HR ($99,474) (dated 20 Dec 2024)

  17. 17 Dec 2024Insiders record

    Lyle Peter F SR (director) bought 10,000 shares of HR ($172,100) (dated 16 Dec 2024)

  18. 9 Dec 2024Filings record

    Director or officer change

  19. 9 Dec 2024Filings record

    Director or officer change

  20. 23 Nov 2024Insiders record

    Bohjalian Thomas N (director) bought 7,750 shares of HR ($134,795) (dated 22 Nov 2024)

  21. 23 Nov 2024Insiders record

    Bohjalian Thomas N (director) bought 4,000 shares of HR ($68,800) (dated 22 Nov 2024)

  22. 12 Nov 2024Filings record

    Director or officer change

  23. 16 Sep 2024Filings record

    Director or officer change

  24. 7 Sep 2024several at once

    had 20.2M shares sold short in the 31 Jul 2024 report, 1.6× the same report last year, while it had 4 insiders buy $892K of its shares on the open market within 30 days (6 filings). Two unrelated kinds of activity within 24 days.

    See the evidence (2 changes)

    Short interest and volume: Short interest spike became public on 10 Aug 2024

    Healthcare Realty Trust had 20.2M shares sold short in the 31 Jul 2024 report, 1.6× the same report last year.

    This period
    20.2M (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    11.5M
    Typical spread (median absolute deviation)
    1.4M
    How far from its usual level
    +4.1
    Same report last year
    12.3M
    History used
    2,406 days
    2023-07-31: 12.3M2023-08-15: 12.2M2023-08-31: 11.9M2023-09-15: 11.5M2023-09-29: 11.5M2023-10-13: 13.6M2023-10-31: 12.4M2023-11-15: 12.4M2023-11-30: 12.4M2023-12-15: 10.7M2023-12-29: 10.0M2024-01-12: 9.4M2024-01-31: 8.8M2024-02-15: 9.6M2024-02-29: 10.1M2024-03-15: 7.5M2024-03-28: 9.1M2024-04-15: 7.3M2024-04-30: 10.1M2024-05-15: 11.0M2024-05-31: 14.5M2024-06-14: 15.6M2024-06-28: 15.0M2024-07-15: 15.3M2024-07-31: 20.2M
    the 31 Jul 2024 report24 earlier reportsnormal: 11.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Insiders: Clustered insider buying became public on 7 Sep 2024

    Healthcare Realty Trust had 4 insiders buy $892K of its shares on the open market within 30 days (6 filings).

    Independent buyers
    4
    Purchase filings (Form 4, code P)
    6
    Total bought
    $892K
    Window
    8 Aug 2024 to 7 Sep 2024

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  25. 7 Sep 2024Insiders change

    had 4 insiders buy $892K of its shares on the open market within 30 days (6 filings).

    Who bought: Bohjalian Thomas N, Lyle Peter F SR, Kilroy James Joseph IV, Singleton John Knox.

    See the evidence (6 source records)
    Independent buyers
    4
    Purchase filings (Form 4, code P)
    6
    Total bought
    $892K
    Window
    8 Aug 2024 to 7 Sep 2024

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  26. 7 Sep 2024Insiders record

    SINGLETON JOHN KNOX (director) bought 6,500 shares of HR ($118,597) (dated 6 Sep 2024)

  27. 7 Sep 2024Insiders record

    Kilroy James Joseph IV (director) bought 12,900 shares of HR ($235,554) (dated 6 Sep 2024)

  28. 5 Sep 2024Insiders record

    Bohjalian Thomas N (director) bought 14,000 shares of HR ($250,320) (dated 4 Sep 2024)

  29. 4 Sep 2024Insiders record

    Lyle Peter F SR (director) bought 1,500 shares of HR ($26,564) (dated 3 Sep 2024)

  30. 21 Aug 2024Insiders record

    Bohjalian Thomas N (director) bought 6,000 shares of HR ($104,700) (dated 20 Aug 2024)

  31. 14 Aug 2024Insiders record

    Bohjalian Thomas N (director) bought 9,000 shares of HR ($156,510) (dated 13 Aug 2024)

  32. 10 Aug 2024Short interest and volume change

    had 20.2M shares sold short in the 31 Jul 2024 report, 1.6× the same report last year.

    Same report last year: 12.3M; its normal report is 11.5M.

    See the evidence
    This period
    20.2M (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    11.5M
    Typical spread (median absolute deviation)
    1.4M
    How far from its usual level
    +4.1
    Same report last year
    12.3M
    History used
    2,406 days
    2023-07-31: 12.3M2023-08-15: 12.2M2023-08-31: 11.9M2023-09-15: 11.5M2023-09-29: 11.5M2023-10-13: 13.6M2023-10-31: 12.4M2023-11-15: 12.4M2023-11-30: 12.4M2023-12-15: 10.7M2023-12-29: 10.0M2024-01-12: 9.4M2024-01-31: 8.8M2024-02-15: 9.6M2024-02-29: 10.1M2024-03-15: 7.5M2024-03-28: 9.1M2024-04-15: 7.3M2024-04-30: 10.1M2024-05-15: 11.0M2024-05-31: 14.5M2024-06-14: 15.6M2024-06-28: 15.0M2024-07-15: 15.3M2024-07-31: 20.2M
    the 31 Jul 2024 report24 earlier reportsnormal: 11.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 25 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 25 Jun 2024Filings record

    Director or officer change

  35. 4 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 4 Mar 2024Filings record

    Director or officer change

  37. 17 Aug 2023Insiders record

    SINGLETON JOHN KNOX (director) bought 31,500 shares of HR ($538,965) (dated 16 Aug 2023)

  38. 10 Mar 2023Insiders record

    Kilroy James Joseph IV (director) bought 2,400 shares of HR ($45,648) (dated 9 Mar 2023)

  39. 9 Mar 2023Insiders record

    Kilroy James Joseph IV (director) bought 10,000 shares of HR ($192,700) (dated 8 Mar 2023)

  40. 7 Mar 2023Financials change

    reported revenue of $4.4M for the quarter ended 31 Dec 2022, 98% below the same quarter last year.

    Same quarter last year: $195.7M; its normal quarter is $188.0M.

    See the evidence
    This period
    $4.4M (the quarter ended 31 Dec 2022)
    Normal quarter (median of 8 earlier)
    $188.0M
    Typical spread (median absolute deviation)
    $3.4M
    How far from its usual level
    -9.8
    Same quarter last year
    $195.7M
    History used
    4,567 days
    2020-09-30: $187.3M2020-12-31: $187.0M2021-03-31: $191.5M2021-06-30: $188.6M2021-09-30: $191.3M2021-12-31: $195.7M2022-06-30: $2.7M2022-09-30: $4.1M2022-12-31: $4.4M
    the quarter ended 31 Dec 20228 earlier quartersnormal: $188.0M

    Fires when the period is at least 3.0 robust standard deviations away from the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

Showing the newest 40 of 112 entries; narrow the window or the kind of data to see older ones.

Not listed: 194 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001360604
Ticker
HR
Domain
healthcarerealty.com
Employer name
Healthcare Realty Trust, Inc. (1 unverified)
Hq location
TN|NASHVILLE|37203 (1 unverified)
Name
150 Taylor Station MOB, LLC, 3310 West End, LLC, 3960 Coon Rapids, LLC, 4765 Carmel Mountain Road, LLC and 484 more
Uei
WSUDK69JCZK1
  • DOL H-1B labor condition applications and PERM certifications36 data points26 Jun 2023 to 18 May 2026
  • SEC Form 13F institutional holdings1 record, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)211 records27 Jan 2016 to 29 Oct 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)806 data points31 Dec 2008 to 26 Oct 2026
  • SEC Form 4 insider transactions50 records, 156 data points3 Jun 2016 to 9 Sep 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards99 data points1 Nov 2019 to 13 Oct 2021